How much funding has Able Sciences raised?

Able Sciences has raised $7.5M in total funding, most recently a Seed round.

Who are Able Sciences's investors?

Able Sciences's investors include SOSV, IndieBio.

When was Able Sciences founded?

Able Sciences was founded in 2023.

Where is Able Sciences headquartered?

Able Sciences is headquartered in Princeton, New Jersey, United States.

What industry is Able Sciences in?

Able Sciences operates in Biotech, Health Care.

How many employees does Able Sciences have?

Able Sciences has 1-10 employees.

Able Sciences

Princeton, United States · Founded 2023 · $7.5M raised

Biotech

Health Care

Headquarters: Princeton, New Jersey
Employees: 1–10
Founded: 2023
Business Model: B2B

Website: ablesciences.com
Total Funding: $7.5M
Last Round: $7.5M SeedJan 2026
Rounds: 1

About

Able Sciences is a biotechnology company developing off-the-shelf, allogeneic cell therapies built on an RNA-based cell-engineering platform. Its lead programs use natural killer (NK) cells engineered to express multiple kill signals in a single step, creating a multivalent, combination-style approach aimed at solid tumors and autoimmune disorders. Backed by SOSV's IndieBio accelerator, the seed-stage company was co-founded in 2023 by CEO Jolly Mazumdar and CSO Thimmaiah Chendrimada.

Summary

Able Sciences is a Biotech company based in Princeton, United States, founded in 2023. It has raised $7.5M in total across 1 round, most recently a $7.5M Seed round in Jan 2026. Investors include SOSV and IndieBio.